>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
持续气道正压通气治疗对中重度阻塞性睡眠呼吸暂停低通气综合征患者肝纤维化标志物的影响
作者:阚海峰  陈龙  杨志云 
单位:如皋市人民医院, 江苏 南通 226500
关键词:阻塞性睡眠呼吸暂停低通气综合征 肝纤维化 持续气道正压通气 
分类号:R563.8;R575.2
出版年·卷·期(页码):2015·34·第一期(113-115)
摘要:

目的:通过对比中重度阻塞性睡眠呼吸暂停低通气综合征患者持续气道正压通气治疗前后肝纤维化标志物的变化,探讨阻塞性睡眠呼吸暂停低通气综合征与肝纤维化之间的关系。方法:选取2010年12月至2013年6月期间在我院门诊和病房确诊为中重度阻塞性睡眠呼吸暂停低通气综合征并行家庭无创通气治疗的患者作为研究对象。检测所有患者治疗前后体质量指数、呼吸暂停低通气指数、最低血氧饱和度、平均血氧饱和度、透明质酸、Ⅲ型前胶原、IV型胶原、层黏连蛋白的水平。结果:所有中重度阻塞性睡眠呼吸暂停低通气综合征患者的体质量指数水平在治疗前后无显著差异(P>0.05);治疗后的呼吸暂停低通气指数水平较治疗前显著下降,平均血氧饱和度、最低血氧饱和度水平显著升高(P<0.05);治疗后的透明质酸、Ⅲ型前胶原、Ⅳ型胶原和层黏连蛋白水平较治疗前均显著下降(P<0.05)。结论:治疗阻塞性睡眠呼吸暂停低通气综合征可以改善肝纤维化程度。

Objective: To investigate the change of continuous positive airway pressure(CPAD) treatment on markers of hepatic fibrosis in patients with severe and moderate obstructive sleep apnea hypopnea syndrome(OSAHS). Methods: According to AHI, We've selected the severe and moderate OSAHS group, from the patients ongoing monitoring of polysomnography in the sleep disorder center in Rugao People's Hospital from December 2010 to June 2013. The BMI, AHI, LSaO2, MSaO2 and plasma HA, PⅢP, ⅣC, LN levels of the patients were compared before and after CPAP treatment. Results: There was no significant difference of the BMI levels before and after CPAP treatment (P >0.05). The LSaO2 and MSaO2 levels were significantly reduced after CPAP treatment (P<0.05). The AHI and plasma HA, PⅢP, ⅣC, LN levels of the patients were significantly increased after CPAP treatment (P<0.05). Conclusion: The CPAP treatment can improve hepatic fibrosis in OSAHS patients.

参考文献:

[1] KALLWITZ E R, HERDEGEN J,MADURA J,et al.Liver enzymes and histology in obese patients with obstructive sleep apnea[J].J Clin Gastroenterol,2007,41:918-921.
[2] MISHRA P, NUGENT C, AFENDY A, et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis[J]. Liver Int,2008,28(8):1080-1086.
[3] TATSUMI K, SAIBARA T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis[J]. Hepatol Res,2005,33(2):100-104.
[4] 中华医学会呼吸病学分会睡眠呼吸障碍学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志,2012,35(1):9-12.
[5] CASTILLO J L,ARAYA F,BUSTAMANTE G,et a1.Use and refuse of nasal CPAP in obstructive sleep apneas/hypopneas[J].Sleep Med,2009,10(Suppl2):S66.
[6] 中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南[J].中华肝脏病杂志,2006,14(11):866-870.
[7] 中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5):327-328.
[8] 王轶娜,陈平.阻塞性睡眠呼吸暂停低通气综合征与非酒精性脂肪性肝病相关性的研究进展[J].中华结核和呼吸杂志,2011,34(1):48-50.《东南大学学报(医学版)》唯一投稿网址:www.ddxbyxb.cn

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405437 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364